関連する実験動画
Updated: Jun 13, 2025
07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
2.3K
腫瘍のニッチからのタウリンは,白血病発生を促進するためにグリコリスを駆動する
Sonali Sharma1,2, Benjamin J Rodems1,2, Cameron D Baker3
1Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Nature
|May 14, 2025
まとめ
白血病の幹細胞は,タウリン-タウリントランスポーター (TAUT) 軸に依存して成長します. システイン・ダイオキシゲナーゼ1型 (CDO1) によるこの軸の阻害は白血病の進行を阻害し,治療の有効性を高めます.
科学分野:
- 血液学
- 癌 生物学
- 分子腫瘍学
背景:
- 幹細胞の自己再生と癌の進行には 微小環境信号が不可欠です
- 癌の進行を促す特定のニッチ駆動信号は知られているが,がん幹細胞受容体リガンドの包括的な地図は欠けている.
研究 の 目的:
- 腫瘍性進行中に白血病幹細胞 (LSCs) と相互作用する骨髄のストロマルニッチの分子シグナルを特定する.
- scRNA-seq,ヒト LSC RNA-seq,およびCRISPRスクリーンデータを統合することにより,白血病発生に不可欠なLSC-ニッチの相互作用をマッピングする.
主な方法:
- テンポラル単細胞RNA配列解析 (scRNA-seq) で,骨髄のニッチをプロファイルする.
- scRNA-seqデータをヒトLSCRNA-seqとインビオCRISPRスクリーンの統合
- TAUT遺伝機能喪失マウスモデルと患者由来急性骨髄性白血病 (AML) 細胞を用いて
主要な成果:
- タウリン-タウリントランスポーター (TAUT) 軸は,攻撃的な骨髄性白血病における重要な依存性として特定されました.
- 骨髄病の進行過程で,システイン二酸化酵素1型 (CDO1) 誘発によるタウリン生物合成が増加する.
- TAUT抑制は,ミエロイド白血病の進行を in vivo 阻害し,AML細胞におけるヴェネトクラックスと相乗効果を発揮した.
結論:
- この研究は,白血病の進行におけるストロマ信号の時間的な風景を確立する.
- タウリンは,骨髄性悪性腫瘍の重要な調節剤として特定されています.
- TAUT抑制はAMLの潜在的な治療戦略であり,特にヴェネトクラックスに耐性のある症例です.
関連する概念動画
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K